Focus research 2022 DynAct team

Advances in cytotoxic T lymphocyte function IOver the past year, the DynAct team’s research has progressed along three main lines:

  • In collaboration with the ATTACK consortium funded by the prestigious European ERC Synergy Grant, the team has helped characterize the lytic compartment of cytotoxic T lymphocytes (CTL). Read article
  • The team has shed new light on the molecular mechanisms by which aggressive tumors such as melanoma resist CTL attack at the lytic synapse. Read the article
  • In collaboration with Dr. Sylvain Cussat-Blanc (Institut de Recherche en Informatique de Toulouse – IRIT), the team has developed a new approach to instance segmentation in microscopy that takes advantage of the highly innovative application called Cartesian Genetic Programming (CGP) of biological images. A patent application has been filed for this program and an article has been submitted for publication (K. Cortacero et al, under revision).

To find out more about the IUCT-Oncopole and CRCT-Oncopole research focuses, please click here

Centre de Recherches en Cancérologie de Toulouse

Centre de Recherches contre le Cancer de Toulouse (Oncopole)

Toulouse - FR

Nous contacter

+33 5 82 74 15 75

Nous rejoindre ?

Pin It on Pinterest